8 AI Drug Discovery and Manufacturing Stocks to Buy

Full Article
8 AI Drug Discovery and Manufacturing Stocks to Buy

Artificial intelligence is revolutionizing the drug discovery industry, with significant economic implications. Goldman Sachs estimates that AI advancements could contribute up to 2.5% to the U.S. GDP, while McKinsey & Co. predicts efficiency gains of 30% in pharmaceuticals. The integration of AI technologies is enabling faster drug development and improved supply chain operations.

Investors are encouraged to consider eight promising stocks in the AI drug discovery space for 2025. Companies like Bristol-Myers Squibb and Eli Lilly are leveraging AI to enhance their research and development processes. The potential for AI to streamline drug discovery and manufacturing presents lucrative opportunities for growth in the pharmaceutical sector.

• AI could add 0.5% to 2.5% to U.S. GDP through drug discovery.

• 75% of healthcare organizations are adopting generative AI technologies.

Key AI Terms Mentioned in this Article

Generative AI

Generative AI refers to algorithms that can create new content or data, enhancing drug discovery processes.

AI Drug Discovery

AI drug discovery utilizes machine learning to identify potential drug candidates more efficiently.

Machine Learning

Machine learning is a subset of AI that enables systems to learn from data and improve over time, crucial for drug development.

Companies Mentioned in this Article

Bristol-Myers Squibb

Bristol-Myers Squibb is integrating AI into its drug discovery and development processes to enhance efficiency.

Eli Lilly

Eli Lilly is investing heavily in AI to optimize drug discovery and clinical trials, aiming for faster market delivery.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 4month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 4month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 4month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 4month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics